Arabesque Asset Management LTD Seagen Inc. Transaction History

Arabesque Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $1.66 Million - $1.97 Million	-11,628 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $291,232 - $347,331	-2,156 Reduced 15.64%	11,628 $1.84 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $1.9 Million - $2.63 Million	13,784 New	13,784 $1.91 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.